Back

Socioeconomic and Demographic Barriers Associated with Delays in Pancreatic Cancer Germline Genetic Testing

2023-07-19 oncology Title + abstract only
View on medRxiv
Show abstract

BackgroundGermline genetic testing is recommended for patients with pancreatic ductal adenocarcinoma (PDAC) and pre-diagnostic testing is offered to patients with a significant family history. However, only 41% of patients in our institution obtained genetic testing. We identified associations between patient social profiles and delays in obtaining germline genetic testing from New Yorks largest healthcare system. MethodsPatients with PDAC were identified using our EMR between Mar 2016 and Feb ...

Predicted journal destinations